期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肝癌及不同发育阶段小鼠肝组织中DNA-PKcs的表达及其对细胞增殖作用的研究 被引量：2

DNA-PKcs expression in hepatoma and normal mouse liver tissues of various developmental stages and its influence on cell proliferation
原文传递
导出
摘要 目的:研究DNA依赖蛋白激酶催化亚基(DNA dependent protein kinase catalytic subunit,DNA-PKcs)在小鼠不同发育阶段肝脏组织和肿瘤组织中的表达,明确其促细胞增殖和在肿瘤发生发展中的作用及机制。方法:采用免疫组织化学方法和蛋白印迹检测小鼠不同发育阶段肝脏组织和肿瘤组织中DNA-PKcs的蛋白表达。通过干扰RNA技术沉默肝肿瘤HepG2细胞中DNA-PKcs的表达,通过细胞增殖实验和裸鼠致瘤实验观察肿瘤细胞增殖和致瘤能力的变化。蛋白印迹法检测细胞增殖相关信号通路蛋白p-GSK3β和c-myc的表达水平。结果:在发育过程中,随着细胞增殖能力降低,肝组织中DNA-PKcs表达水平下降,在成年鼠肝组织中DNA-PKcs只有微弱表达。而在肿瘤组织细胞中DNA-PKcs表达显著增高(P<0.01)。细胞生长曲线结果显示,DNA-PKcs表达抑制后,HepG2细胞增殖能力受到明显抑制(P<0.01),致瘤能力也显著降低。信号通路蛋白分析发现DNA-PKcs抑制导致GSK3β磷酸化水平和c-myc蛋白水平降低(P<0.01)。结论:DNA-PKcs表达水平与肝脏细胞的增殖能力密切相关。DNA-PKcs的高表达可能通过调节细胞的增殖,参与肝脏肿瘤的发生和发展过程,作用机制和Wnt/GSK/c-myc信号通路相关。 Objective：To observe the expression of DNA dependent protein kinase catalytic subunit（DNA-PKcs） in the hepatoma tissues and mouse liver tissues of different developmental stages,so as to understand the role of DNA-PKcs in cell proliferation and tumorigenesis.Methods： Immunohistochemistry and Western blotting assay were used to observe the protein expression of DNA-PKcs in liver tissues and hepatoma tissues.The siRNA technique was used to silence the expression of DNA-PKcs in the HepG2 cells;cell proliferation assay and tumor transplantation test in nude mice were performed to evaluate the changes of the proliferation ability and tumorigenesis.Western blotting assay was also conducted to examine the expression of proliferation related proteins p-GSK3β and c-myc.Results： DNA-PKcs expression decreased in the liver tissues with the decrease of cell proliferation ability during the development of mice,and the expression level of DNA-PKcs was weak in liver tissues of adult mouse;but the DNA-PKcs protein level in the hepatoma tissues was significantly elevated（P〈0.01）.Cell growth curve showed that the proliferation of HepG2 cells was significantly decreased after suppression of DNA-PKcs with siRNA（P〈0.01）,accompanied by a suppressed tumorigenesis ability.The expression of signal pathway related protein p-GSK3β and c-myc was inhibited after DNA-PKcs silencing in HepG2 cells（P〈0.01）.Conclusion： DNA-PKcs expression level is closely related to the proliferation ability of liver cells.Overexpression of DNA-PKcs may participate in the development and progression of hepatoma through mediating cell proliferation via the Wnt/GSK/c-myc related signal pathway.
作者 黄越承 周平坤 蔡建明 徐勤枝 李百龙 高福 钟玉芳 安静
机构地区 第二军医大学海军医学系放射医学教研室 军事医学科学院放射毒理学研究室 上海大学环境污染与健康研究所
出处 《第二军医大学学报》 CAS CSCD 北大核心 2009年第11期1217-1220,共4页 Academic Journal of Second Military Medical University
基金 国家重点基础研究发展计划(“973”计划,2008CB418205) 上海市重点学科资助项目(S30109)~~
关键词 DNA-PKCS 肝肿瘤 肝 生长和发育 细胞增殖 GSK3Β C-MYC DNA-PKcs liver neoplasms liver growth and development cell proliferation GSK3β c-myc
分类号 R730.231 [医药卫生—肿瘤]
  • 相关文献

参考文献15

  • 1Jackson S P. Sensing and repairing DNA double-strand breaks [J]. Carcinogenesis, 2002,23 : 687-696.
  • 2Williams E S,Klingler R,Ponnaiya B, Hardt T,Schrock E,Lees-Miller S P, et al. Telomere dysfunction and DNA-PKcs deficiency: characterization and consequence[J]. Cancer Res,2009,69:2100-2107.
  • 3Shi M, Vivian C J, Lee K J,Ge C, Morotomi-Yano K, Manzl C, et al. DNA-PKcs-PIDDosome: a nuclear caspase-2-activating complex with role in G2/M checkpoint maintenanee[J]. Cell, 2009,136 : 508-520.
  • 4Moll U,Lau R,Sypes M A,Gupta M M,Anderson C W. DNAPK, the DNA-activated protein kinase,is differentially expressed in normal and malignant human tissues[J]. Oncogene, 1999,18:3114-3126.
  • 5Holgersson A, Erdal H, Nilsson A, Lewensohn R, Kanter L. Expression of DNA-PKcs and Ku86, but not Ku70,differs between lymphoid malignancies[J]. Exp Mol Pathol, 2004,77 : 1-6.
  • 6Um J H, Kwon J K, Kang C D, Kim M J,Ju D S, Bae J H,et al. Relationship between antiapoptotic molecules and metastatic potency and the involvement of DNA-dependent protein kinase in the chemosensitlzation of metastatic human caneer cells by epidermal growth factor receptor hlockade[J]. J Pharmacol Exp Ther,2004,311:1062-1070.
  • 7Ortiz T, Burguillos M A, Lopez-Llueh G, Navas P, Herrador M, Gonzdlez I,et al. Enhanced induction of apoptosis in a radio-resistant bladder tumor cell line by combined treatments with X-rays and wortmannin[J]. Radiat Environ Biophys, 2008,47: 445-452.
  • 8Tian X,Chen G,Xing H,Weng D,Guo Y,Ma D,et al. The relationship between the down-regulation of DNA-PKcs or KuTO and the chemosensitization in human cervical carcinoma cell line HeLa[J]. Oncol Rep, 2007,18 : 927-932.
  • 9Hosoi Y, Watanabe T, Nakagawa K, Matsumoto Y, Enomoto A, Morita A. Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer[J]. Int J Oncol,2004,25:461-468.
  • 10Liu L X,Jiang H C, Liu Z H,Zhu A L,Zhou J,Zhang W H,et al. Gene expression profiles of hepatoma cell line BEL-7402[J]. Hepatogast roenterology, 2003,50 : 1496-1501.

二级参考文献13

  • 1Mi K,Dolan PJ,Johnson GV.The low density lipoprotein receptor-related protein 6 interacts with glycogen synthase kinase 3 and attenuates activity[J].J Biol Chem,2006,281 (8):4787 -4794.
  • 2DasGupta R,Kaykas A,Moon RT,et al.Functional genomic analysis of the WNT-wingless signaling pathway[J].Science,2005,308 (5723):826-833.
  • 3Katoh Y,Katoh M.Hedgehog signaling pathway and gastric cancer[J].Cancer Biol Ther,2005,4(10):1050 -1054.
  • 4Dihlmann S,von Knebel Doeberitz M.WNT/beta-cateninpathway as a molecular target for future anti-cancer therapeutics[J].Int J Cancer,2005,113(4):515 -524.
  • 5Dihlmann S,Klein S,Doeberitz Mv MK.Reduction of beta-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-catenin[J].Mol Cancer Ther,2003,2(6):509 -516.
  • 6Rice PL,Kelloff J,Sullivan H,et al.Sulindac metabolites induce caspase-and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells[J].Mol Cancer Ther,2003,2(9):885-892.
  • 7Boon EM,Keller JJ,Wormhoudt TA,et al.Sulindac targets nuclear beta-catenin accumulation and WNT signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines[J].Br J Cancer,2004,90 (1):224-229.
  • 8Bug G,Gul H,Schwarz K,et al.Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells[J].Cancer Res,2005,65(7):2537 -2541.
  • 9Danilkovitch-Miagkova A.Oncogenic signaling pathways activated by RON receptor tyrosine kinase[J].Curr Cancer Drug Targets,2003,3 (1):31-40.
  • 10Hanai J,Gloy J,Karumanchi SA.Endostatin is a potential inhibitor of WNT signaling[J].J Cell Biol,2002,158(3):529 -539.

共引文献16

同被引文献17

  • 1高国兰,万红英,黄传生,邹学森,陈文学.P-gp、GST-π、TS蛋白在宫颈癌中的表达及临床意义[J].临床肿瘤学杂志,2007,12(1):23-26. 被引量：11
  • 2Someya M,Sakata K,Matsumoto Y,et al.The association of DNA-dependent protein kinase activity with chromosomal instability and risk of cancer[J].Carcinogenesis,2006,27(1):117-122.
  • 3Curtin NJ.DNA repair dysregulation from cancer driver to therapeutic target[J].Nat Rev Cancer,2012,12(12):801-817.
  • 4Rothkamm K,Krüger I,Thompson LH,et al.Pathways of DNA double-strand break repair during the mammalian cell cycle[J].Mol Cell Biol,2003,23:5706-5715.
  • 5Woods DS,Sears CR,Turchi JJ.Recognition of DNA termini by the C-terminal region of the ku80and the DNA-dependent protein kinase catalytic subunit[J].Plos One.2015,10(5):1-19.
  • 6Gareth J,Williams,Michal Hammel,et al.Structural insights into NHEJ:building up an integrated picture of the dynamic DSB repair super complex,one component and interaction at a time[J].DNA Repair(Amst),2014,17:110-120.
  • 7Seo SB,Hur JG,Kim MJ,et al.TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3beta pathway and activation of caspases[J].Mol Cancer,2010,28(9):199.
  • 8Ryu JS,Um JH,Kang CD,et al.Fractionated irradiation leads to restoration of drug sensitivity in MDR cells that correlates with down-regulation of P-gp and DNA-dependent protein kinase activity[J].Radiat Res,2004,162(5):527-535.
  • 9Nishida Y,Mizutani N,Inoue M,et al.Phosphorylated Sp1is the regulator of DNA-PKcs and DNA ligase IV transcription of daunorubicin-resistant leukemia cell lines[J].Biochim Biophys Acta,2014,1839(4):265-274.
  • 10江娜,沈瑛,孔宪明,糜军.DNA-PK蛋白功能及其调控机制[J].医学分子生物学杂志,2011,8(3):278-282. 被引量：3

引证文献2

二级引证文献3

第二军医大学学报
2009年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部